Ramer Â· Alavi Nuclear Medicine Technology

More documents

Recommendations

Info

14) The philosophy of the ALARA program is to keep theradiation dose:a. as low as recently authorizedb. as long as reasonably attainedc. as long as reasonably acceptabled. as low as reasonably achievable15) All of the following are critical factors in keepingradiation exposure to a minimum except:a. time spent near the a radioactive sourceb. geometry of the container holding the sourceof radiationc. distance from the source of radiationd. shielding of the radioactive source3 Radiation Safety 2316) Gaseous radiopharmaceuticals may only be used inrooms that:a. have at least one windowb. contain an oxygen supplyc. are at a positive pressure compared to surroundingroomsd. are at a negative pressure compared to surroundingrooms17) If the exposure rate at 4 meters from a radioactivesource is 5 mR/hr, what will the exposure rate be at3 meters?a. 2.8 mR/hrb. 6.5 mR/hrc. 7.4 mR/hrd. 8.9 mR/hr
243 Radiation Safety18) If the exposure rate at 10 meters from a radioactivesource is 15 mR/hr, what will the exposure rate be at25 meters?a. 2.4 mR/hrb. 6 mR/hrc. 3 mR/hrd. 10 mR/hr19) A spill of 99m Tc increases the exposure rate in a roomfrom 1.7 mR/hr to 3.15 mR/hr. The room is posted witha sign reading “Caution-Radioactive Materials”. Whatwould be the ideal solution?a. change the sign to one reading “Caution-RadiationArea”b. call the NRCc. decontaminate the floor with water and cleanserd. place absorbent paper over the spill and close theroom until the activity has decayed20) A technologist has 500 mrem registered on his ringbadge in one month. What should be done to decreaseexposure in the future?a. use lead pigs and syringe shields when preparingradiopharmaceuticalsb. have another technologist elute the generatorc. wear lead apronsd. all of the above21) OSHA requires that personnel exposure records beprovided to employees:a. monthlyb. quarterlyc. annuallyd. biannually
Page 5 and 6: Table of Contents1 Introduction . .
Page 7 and 8: 21 IntroductionIn response to all o
Page 9 and 10: 42 Radioactivity, Radiopharmacy, an
Page 11 and 12: 62 Radioactivity, Radiopharmacy, an
Page 13: 82 Radioactivity, Radiopharmacy, an
Page 17 and 18: 122 Radioactivity, Radiopharmacy, a
Page 25 and 26: 3 Radiation Safety1) Which of the f
Page 27: 223 Radiation Safety9) Which of the
Page 31 and 32: 263 Radiation Safety25) What is the
Page 33 and 34: 283 Radiation Safety33) A technolog
Page 35 and 36: 303 Radiation Safety42) What length
Page 37 and 38: 324 Instrumentation and Quality Ass
Page 53 and 54: 485 Image Presentation and Computer
Page 55 and 56: 505 Image Presentation and Computer
Page 57 and 58: 6 Skeletal System Scintigraphy1) Wh
Page 59 and 60: 546 Skeletal System Scintigraphy10)
Page 67 and 68: 7 Central Nervous System Scintigrap
Page 69 and 70: 647 Central Nervous System Scintigr
Page 75 and 76: 708 Cardiovascular System Scintigra
Page 77 and 78: 728 Cardiovascular System Scintigra
Page 79 and 80:
748 Cardiovascular System Scintigra
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
9 Respiratory System Scintigraphy1)
Page 93 and 94:
889 Respiratory System Scintigraphy
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
10 Gastrointestinal Tract Scintigra
Page 103 and 104:
9810 Gastrointestinal Tract Scintig
Page 105 and 106:
10010 Gastrointestinal Tract Scinti
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
11 Genitourinary System Scintigraph
Page 113 and 114:
10811 Genitourinary System Scintigr
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
11812 Neoplasm and Infection Scinti
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
13 Thyroid, Parathyroid,and Salivar
Page 133 and 134:
12813 Thyroid, Parathyroid, and Sal
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
14 Non-Imaging Proceduresand Radion
Page 143 and 144:
13814 Non-Imaging Procedures and Ra
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
15 Patient Care1) Which of the foll
Page 153 and 154:
14815 Patient Care10) Of the follow
Page 155 and 156:
15015 Patient Care18) According to
Page 157 and 158:
16 Mock Examination1) In which radi
Page 159 and 160:
15416 Mock Examination8) A whole bo
Page 161 and 162:
15616 Mock Examination17) The infer
Page 163 and 164:
15816 Mock ExaminationFigure 16.224
Page 165 and 166:
16016 Mock Examination29) Which of
Page 167 and 168:
16216 Mock Examination37) If a pati
Page 169 and 170:
16416 Mock Examination43) A sentine
Page 171 and 172:
16616 Mock Examination53) First pas
Page 173 and 174:
16816 Mock Examination61) What is t
Page 175 and 176:
17016 Mock Examination71) If a SPEC
Page 177 and 178:
17216 Mock Examination79) When inje
Page 179 and 180:
17416 Mock Examination87) To minimi
Page 181 and 182:
Appendix1761.a2.d3.c4.c5.b6.c7.d8.b
Page 183 and 184:
Appendix1781.c2.b3.d4.b5.c6.c7.b8.c
show all

Ramer Â· Alavi Nuclear Medicine Technology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?